March 13, 2025 (EIRNS)—China’s National Medical Products Administration (NMPA) published a report on the role of fentanyl in the Chinese economy and exports, countering the U.S. claim that Beijing is pumping huge quantities of the killer drug into the U.S. through Mexico and Canada. Under the title “China Has Never Exported Fentanyl-Related Medications to North America: NMPA,” they report that fentanyl-related medications are primarily used for pain relief in clinical settings. “China’s State Council Information Office released a white paper on March 4, 2025, titled ‘Controlling Fentanyl-Related Substances—China’s Contribution,’ highlighting the country’s rigorous control over these chemicals. The spokesperson noted that in 2024, China produced 100 kilograms of fentanyl-based active pharmaceutical ingredients, primarily for domestic medical use and export. That year, China exported 12.3 kilograms of fentanyl-related medications, measured as fentanyl-related substances, mainly to South Korea, Vietnam, and the Philippines.”